MetaSafe will be attending Nordic Life Science Days (NLSDays) in Stockholm on 8-9 September 2026. As one of the largest partnering and networking events for the Nordic life science community, NLSDays provides a valuable platform for connecting with pharmaceutical companies, biotech innovators, investors, and service providers.
The event offers a unique opportunity to discuss current challenges and opportunities within drug development and to explore how scientific collaboration can accelerate project success. MetaSafe will be represented by Johanna Haglund and Virginia Aimetta, who look forward to meeting both existing and prospective clients.
Visitors are invited to learn more about MetaSafe’s expertise in metabolism studies, metabolite identification, metabolite profiling, exposure assessments, and scientific consulting. We are particularly enthusiastic about discussing strategies for addressing metabolism-related questions throughout the drug development process, from discovery through late-stage development.
If you are planning to attend NLSDays, we would be delighted to connect and discuss how MetaSafe can support your scientific and development objectives.